Xiaodan Li
Southern Medical University
16 Papers
25 Citations
Xiaodan Li is an academic researcher from Southern Medical University. The author has contributed to research in topics: Medicine & Pretargeting. The author has an hindex of 4, co-authored 15 publications.
Chat about Author
Papers
Whole-tumor histogram analysis of apparent diffusion coefficient in differentiating intracranial solitary fibrous tumor/hemangiopericytoma from angiomatous meningioma.
TL;DR: Whole-tumor histogram analysis of ADC maps may be a useful tool for differential diagnosis, with ADCmin and ADC5 being potential parameters.
32
Machine Learning-Based Multiparametric Magnetic Resonance Imaging Radiomic Model for Discrimination of Pathological Subtypes of Craniopharyngioma
Zhou-San Huang,Xiang Xiao,Xiaodan Li,Hai-Zhu Mo,Wenle He,Yao-Hong Deng,Lijun Lu,Yuankui Wu,Hao Liu +8 more
TL;DR: In this paper, the authors developed a radiomic model based on multiparametric magnetic resonance imaging for noninvasive discrimination of pathological subtypes of craniopharyngioma.
17
Imaging algorithm and multimodality evaluation of spinal osteoblastoma.
Zihuan Huang,Tingsong Fang,Zhiguang Si,Youcai Li,Lan Zhang,Chunling Zheng,Shenmei Li,Manting Su,Xiaomin Liu,Xiaodan Li,Yuankui Wu +10 more
TL;DR: Although a larger sample size is needed, combining CT, MRI and PET may be beneficial to optimize preoperative diagnosis and care of patients with OBs.
Association of Glioma Grading With Inflow‐Based Vascular‐Space‐Occupancy MRI: A Preliminary Study at 3T
Xiaodan Li,Shukun Liao,Jun Hua,Liuji Guo,Danni Wang,Xiang Xiao,Jun Zhou,Xiaomin Liu,Yuefa Tan,Lijun Lu,Yikai Xu,Yuankui Wu,Yuankui Wu +12 more
TL;DR: Inflow‐based vascular‐space‐occupancy (iVASO) MRI is a noninvasive perfusion technique that does not require administration of exogenous contrast agents.
12
Detecting GPC3-Expressing Hepatocellular Carcinoma with L5 Peptide-Guided Pretargeting Approach: In Vitro and In Vivo MR Imaging Experiments
TL;DR: L5 peptide-guided, two-step pretargeting approach with USPIO as the MR imaging probe is a lucrative strategy to specifically identify GPC3-expressing HCC.